AXGN
Axogen IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.69B
P/E Ratio
—
EPS
$-0.34
Beta
0.98
52W High
$36.00
52W Low
$9.22
50-Day MA
$32.76
200-Day MA
$23.34
Dividend Yield
—
Profit Margin
-6.97%
Forward P/E
133.33
PEG Ratio
99.04
About Axogen Inc
AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida.
Fundamentals
| Revenue (TTM) | $225.21M |
| Gross Profit (TTM) | $167.35M |
| EBITDA | -874,000 |
| Operating Margin | -16.30% |
| Return on Equity | -13.50% |
| Return on Assets | -2.31% |
| Revenue/Share (TTM) | $4.89 |
| Book Value | $2.73 |
| Price-to-Book | 13.87 |
| Price-to-Sales (TTM) | 7.52 |
| EV/Revenue | 8.05 |
| EV/EBITDA | 3576.84 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 21.30% |
| Shares Outstanding | $51.90M |
| Float | $50.77M |
| % Insiders | 2.12% |
| % Institutions | 85.47% |
Analyst Ratings
Consensus ($40.56 target)
2
Strong Buy7
BuyData last updated: 4/7/2026